Valvular heart disease (VHD), clinically manifested as stenosis and regurgitation of native
heart valve, is one of the most prevalent cardiovascular diseases with high mortality. Heart …

Valvular heart disease is a major threat to human health and transcatheter heart valve
replacement (THVR) has emerged as the primary treatment option for severe heart valve …

In recent years, the number of heart valve replacements has multiplied with valve diseases
because of aging populations and the surge in rheumatic heart disease in young people …

With the aging of the population in worldwide, valvular heart disease has become one of the
most prominent life-threatening diseases in human health, and heart valve replacement …

With the advancement of minimally invasive interventional therapy, biological heart valves
(BHVs) have been extensively used in clinics. However, BHVs are generally prone to …

Over one million artificial heart valve transplantations are performed each year due to
valvular stenosis or regurgitation. Among them, bioprosthetic heart valves (BHVs) are …

Valvular heart disease (VHD) has become a burden and a growing public health problem in
humans, causing significant morbidity and mortality worldwide. An increasing number of …

With the development of diagnostic techniques, the incidence of bioprosthetic heart valve
thrombosis (BHVT) is found to be seriously underestimated. Developing bioprosthetic heart …

The bioprosthetic heart valves (BHVs) are the best option for the treatment of valvular heart
disease. Glutaraldehyde (Glut) is commonly used as the golden standard reagent for the …

Bioprosthetic heart valves (BHVs) have been widely used due to the revolutionary
transcatheter aortic valve replacement (TAVR) techniques but suffer from a limited lifespan …